HCA Healthcare, Inc. · Healthcare · Medical Care Facilities
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$529.71
+$3.83 (+0.73%) 4:00 PM ET
Prev closePrevC$525.88
OpenOpen$523.50
Day highHigh$532.63
Day lowLow$523.50
VolumeVol1,813,372
Avg volAvgVol1,228,141
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$118.45B
P/E ratio
18.69
FY Revenue
$75.60B
EPS
28.34
Gross Margin
100.00%
Sector
Healthcare
AI report sections
MIXED
HCA
HCA Healthcare, Inc.
HCA combines solid multi-period price appreciation and positive momentum signals with overbought technical readings and a stretched position versus key moving averages. Fundamentally, the company shows steady revenue, earnings, and cash flow growth with healthy margins and free cash flow generation but operates with very high leverage, minimal equity, and tight liquidity ratios. Valuation appears moderate on earnings and cash flow metrics while the balance sheet structure and elevated short-volume activity introduce non-trivial risk considerations.
AI summarized at 10:51 AM ET, 2026-01-27
AI summary scores
INTRADAY:63SWING:71LONG:77
Volume vs average
Intraday (cumulative)
+99% (Above avg)
Vol/Avg: 1.99×
RSI
55.99(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
-0.30 (Weak)
MACD: -0.55 Signal: -0.25
Short-Term
+0.03 (Strong)
MACD: 12.72 Signal: 12.68
Long-Term
+2.21 (Strong)
MACD: 15.26 Signal: 13.04
Intraday trend score
68.01
LOW48.01HIGH68.01
Latest news
HCA•12 articles•Positive: 7Neutral: 5Negative: 0
PositiveThe Motley Fool• Jonathan Ponciano
This Fund Sold $38 Million in Appian Stock Last Quarter. Shares Have Fallen Over 25% This Year
Abdiel Capital Advisors sold 1,075,738 shares of Appian (worth $38.32 million) in Q4 2025, reducing its stake to 12.4% of assets. Appian shares have fallen 28.1% over the past year and underperformed the S&P 500 by 39.1 percentage points. Despite the reduction, Abdiel maintains a double-digit allocation, suggesting risk management rather than abandonment of the investment thesis.
Listed as Abdiel Capital's top holding at 44.2% of AUM ($31.39 million), indicating strong confidence and allocation priority within the fund's portfolio.
PositiveThe Motley Fool• Prosper Junior Bakiny
1 Unstoppable Healthcare Stock to Buy and Hold
HCA Healthcare, a major medical facilities operator, delivered strong Q4 2025 results with 6.7% revenue growth and 28.8% EPS growth. Despite modest 3.5% revenue guidance for 2026 due to expired premium tax credits and regulatory uncertainty, the company is well-positioned for long-term growth driven by aging populations and AI-enhanced healthcare initiatives.
HCAhealthcare stocksHCA Healthcaremedical facilitiesearnings growthregulatory uncertaintyaging populationartificial intelligence in healthcare
Sentiment note
Strong Q4 2025 financial performance with 6.7% revenue growth and 28.8% EPS jump. Stock up 7% YTD in 2026. Company demonstrates resilience amid regulatory challenges and has significant long-term growth opportunities from aging populations and AI-driven initiatives. Analyst recommends holding for long-term above-average returns despite near-term volatility.
PositiveThe Motley Fool• Prosper Junior Bakiny
2 High-Flying Growth Stocks to Buy and Hold for 10 Years
The article recommends Robinhood Markets and HCA Healthcare as strong 10-year investment opportunities. Robinhood is positioned to benefit from its popularity among younger investors and expanding services including AI tools and prediction markets, despite valuation concerns and crypto volatility. HCA Healthcare is well-positioned to capitalize on demographic shifts as the aging population increases healthcare demand, with a diversified payer mix helping mitigate reimbursement risks.
Well-positioned to benefit from aging U.S. population increasing healthcare demand through 2036; demonstrated ability to grow market share over 15 years; diversified payer mix reduces reimbursement risk; strong 2025 performance with higher service utilization and favorable reimbursement rates.
PositiveBenzinga• Eva Mathew
OpenAI Buys Healthcare Startup Torch Days After Launching ChatGPT Health
OpenAI acquired healthcare startup Torch for approximately $60-100 million, days after launching ChatGPT Health. Torch was designed as a unified medical memory platform consolidating patient data from hospitals, labs, and wearables. The four-person team will join OpenAI as part of the acquisition. This move is part of OpenAI's broader expansion into healthcare with enterprise-grade products for health systems like HCA Healthcare.
HCAOpenAITorch acquisitionChatGPT Healthhealthcare technologymedical dataAI in healthcareHCA Healthcare
Sentiment note
HCA Healthcare is mentioned as an initial partner for OpenAI's healthcare products, positioning the company to benefit from advanced AI-powered healthcare solutions and potentially improving operational efficiency.
NeutralThe Motley Fool• Josh Kohn-Lindquist
Darsana Capital Opens New $189 Million Wingstop Position: Is the Stock a Buy?
Darsana Capital initiated a new $189 million stake in Wingstop, purchasing 750,000 shares representing 4.45% of their portfolio. Despite recent same-store sales declines, the investment suggests potential long-term growth in the restaurant chain.
Consistent revenue growth but more expensive valuation compared to Tenet, with lower EBITDA margins and growth rates
NeutralThe Motley Fool• Josh Kohn-Lindquist
Abdiel Capital Liquidates Massive $113 Million Floor & Decor Stake: Should Investors Follow Suit?
Abdiel Capital fully exited its position in Floor & Decor Holdings, selling 1,482,936 shares worth $112.64 million, reducing its assets under management and potentially signaling concerns about the company's performance and housing market conditions.
HCA Healthcare reported strong Q3 2025 financial results, with revenues of $19.16 billion (9.6% YoY increase) and adjusted earnings of $6.96. The hospital operator saw growth in patient admissions, surgeries, and raised its fiscal year 2025 guidance.
Exceeded analyst expectations, increased revenues, raised fiscal year guidance, reported growth in patient admissions and surgeries, and saw stock trading at a 52-week high
PositiveThe Motley Fool• Prosper Junior Bakiny
2 Outstanding Healthcare Stocks to Buy and Hold for a Decade
Two healthcare companies, HCA Healthcare and TransMedics Group, show promising long-term potential due to their innovative strategies, market positioning, and ability to adapt to industry changes.
Consistently increasing market share, strong financial performance, extensive facility network, and high barriers to entry in the healthcare industry
NeutralBenzinga• Akanksha Bakshi
Premier Set For Private Ownership, Eyes Growth Push
Premier Inc. will be acquired by Patient Square Capital for $28.25 per share, representing a 23.8% premium to its 60-day average closing price. The deal aims to improve financial flexibility and accelerate investments in technology and services.
Mentioned in article but not directly involved in the transaction
NeutralGlobeNewswire Inc.• Dr. Matthew Albert
EndoQuest Advances Multicenter PARADIGM Trial with Completion of Procedure at AdventHealth Orlando
EndoQuest Robotics is conducting a multicenter clinical trial (PARADIGM Trial) to evaluate its Endoluminal Surgical (ELS) System for minimally invasive colorectal lesion removal across five U.S. healthcare institutions.
Participating in clinical trial as a research site
PositiveInvesting.com• Sam Quirke
Can HCA Healthcare Revive the Market’s Weakest Sector?
HCA Healthcare demonstrates strong performance in a struggling healthcare sector, outperforming market trends with a 14% gain in 2025, driven by strategic acquisitions and robust financial results.
Reported Q2 EPS of $6.84 vs expectations of $6.20, revenues of $18.61 billion, 6th consecutive quarterly beat, 13.1% net income increase, forecasting 12.21% EPS growth next year
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal